Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-008526

EVP, R&D & Chief Scientific Of sold 12,375 shares at an average $38.62 ($477,922)

  • EVP, R&D & Chief Scientific Of gave up 1,512 shares (to pay taxes)
  • EVP, R&D & Chief Scientific Of acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Haqq Christopher EVP, R&D & Chief Scientific Of 2019-02-06 Sale −2,677 $38.04 $101,833 282,903 D
Haqq Christopher EVP, R&D & Chief Scientific Of 2019-02-06 Sale −9,698 $38.78 $376,088 273,205 D
Haqq Christopher EVP, R&D & Chief Scientific Of 2019-02-06 Shares withheld for taxes −1,512 $38.47 $58,167 271,693 D
Haqq Christopher EVP, R&D & Chief Scientific Of 2019-02-06 Grant or award +15,000 286,693 D
Derivatives
Haqq Christopher EVP, R&D & Chief Scientific Of 2019-02-06 Grant or award · Employee Stock Option (Right to Buy) +30,000 30,000 D
Open-market sales · 12,375 sh · avg $38.62 · $477,922
Loading xslF345X03/doc4.xml…